Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-5,136
Closed -$32.1K 1143
2023
Q4
$32.1K Hold
5,136
﹤0.01% 816
2023
Q3
$24.5K Hold
5,136
﹤0.01% 767
2023
Q2
$30.7K Buy
+5,136
New +$41.2K ﹤0.01% 696
2023
Q1
Sell
-5,136
Closed -$63.7K 1012
2022
Q4
$63.7K Sell
5,136
-49,064
-91% -$861K ﹤0.01% 1055
2022
Q3
$1.12M Buy
54,200
+2,500
+5% +$69.5K 0.02% 679
2022
Q2
$1.43M Buy
51,700
+49,064
+1,861% +$1.68M 0.02% 644
2022
Q1
$115K Hold
2,636
﹤0.01% 1179
2021
Q4
$146K Buy
+2,636
New +$163K ﹤0.01% 1097
2016
Q3
Sell
-1,919
Closed -$48K 336
2016
Q2
$48K Buy
+1,919
New +$70.2K 0.01% 444

Other funds holding AFMD

LMR Partners's AFMD Position: Q1 2024 in Review

LMR Partners sold out of Affimed (AFMD) in Q1 2024, closing a stake of 5,136 shares — an estimated $32.1K sold.

LMR Partners first reported a position in AFMD in Q2 2016 and held it in 9 quarters. The position peaked at $1.43M in Q2 2022. 46 funds tracked by Wall St. Rank hold AFMD as of Q1 2024.

  • LMR Partners reported no remaining Affimed position as of Q1 2024 after selling out during the quarter.
  • LMR Partners sold 5,136 Affimed shares in Q1 2024, an estimated $32.1K.
  • LMR Partners first reported a position in Affimed in Q2 2016 and held it in 9 quarters.
  • LMR Partners's Affimed position peaked at $1.43M in Q2 2022.
  • 46 funds tracked by Wall St. Rank held Affimed as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.